EGenesis
Nov 12, 2020
FDA authorizes first diagnostic test for Covid-19 antibodies; EGenesis’s collaboration with Duke; Pancreatic Cancer research updates; Decibel scores $ 82 M
FDA authorizes first diagnostic test for COVID-19 antibodies that obstruct the virus from entering cells The FDA has authorized the first COVID-19 diagnostic test, which identifies whether a person has the specific antibodies known to hinder the coronavirus from entering and infecting human cells. These neutr...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
